Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

18F-DOPA PET Imaging: an Evaluation of Biodistribution and Safety

NCT03042416 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT03042416
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03042416 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
18F-DOPA PET Imaging: an Evaluation of Biodistribution and Safety
Lead sponsor
University of Alberta
Phase
Phase 3
Overall status
Completed
Start date
June 29, 2017
Completion date
June 2, 2021
Enrollment
400 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain glioma, congenital hyperinsulinism, neuroblastoma, neuroendocrine tumors, parkinson disease